Literature DB >> 10548367

Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy.

A D Smith1, B Bagheri, R D Streilein, R P Hall.   

Abstract

Although possessing a morphologically similar small bowel abnormality to patients with isolated gluten-sensitive enteropathy (GSE), patients with dermatitis herpetiformis (DH) have few gastrointestinal symptoms and exhibit blistering skin lesions and cutaneous IgA deposits. To determine whether clinical discrepancies between these gluten-sensitive conditions might be the result of different patterns of small bowel cytokine expression, duodenal biopsies were obtained from eight DH patients and nine isolated GSE patients. Biopsies were evaluated for interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) expression by reverse-transcriptase polymerase chain reaction (message) and immunohistochemistry (protein). In DH patients, most of whom had no gut symptoms, IFN-gamma mRNA expression was significantly less than in isolated GSE patients with symptomatic gut disease. Conversely, IL-4 mRNA expression in DH patients was greater than that found among isolated GSE patients. These findings suggest that the different clinical phenotypes of gluten sensitivity may be caused by variation in cytokine expression in the small bowel response to gluten.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548367     DOI: 10.1023/a:1026699108147

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

Review 1.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease.

Authors:  C G Beckett; D Dell'Olio; M Kontakou; R T Przemioslo; S Rosen-Bronson; P J Ciclitira
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

3.  Coeliac syndrome in dermatitis herpetiformis.

Authors:  S Shuster; A J Watson; J Marks
Journal:  Lancet       Date:  1968-05-25       Impact factor: 79.321

4.  The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesion and associated malabsorption.

Authors:  J R Brow; F Parker; W M Weinstein; C E Rubin
Journal:  Gastroenterology       Date:  1971-03       Impact factor: 22.682

5.  Structure and function of the small intestine in dermatitis herpetiformis.

Authors:  N G Fraser; D Murray; J O Alexander
Journal:  Br J Dermatol       Date:  1967-10       Impact factor: 9.302

Review 6.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

7.  In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.

Authors:  R L Modlin; F M Hofman; D A Horwitz; L A Husmann; S Gillis; C R Taylor; T H Rea
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; G A Limb; H J Ellis; P Day; P J Ciclitira
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  1 in total

1.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.